Daniel S Loeb Net Worth

The estimated Net Worth of Daniel S Loeb is at least $33.7 Million dollars as of 18 September 2018. Daniel Loeb owns over 800,000 units of Third Point Reinsurance Ltd stock worth over $23,192,789 and over the last 19 years Daniel sold TPRE stock worth over $10,520,000.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Daniel Loeb TPRE stock SEC Form 4 insiders trading

Daniel has made over 1 trades of the Third Point Reinsurance Ltd stock since 2018, according to the Form 4 filled with the SEC. Most recently Daniel sold 800,000 units of TPRE stock worth $10,520,000 on 18 September 2018.

The largest trade Daniel's ever made was selling 800,000 units of Third Point Reinsurance Ltd stock on 18 September 2018 worth over $10,520,000. On average, Daniel trades about 160,000 units every 0 days since 2005. As of 18 September 2018 Daniel still owns at least 5,086,138 units of Third Point Reinsurance Ltd stock.

You can see the complete history of Daniel Loeb stock trades at the bottom of the page.

What's Daniel Loeb's mailing address?

Daniel's mailing address filed with the SEC is THIRD POINT LLC, 390 PARK AVENUE, NEW YORK, NY, 10022.

Insiders trading at Third Point Reinsurance Ltd

Over the last 11 years, insiders at Third Point Reinsurance Ltd have traded over $748,870,944 worth of Third Point Reinsurance Ltd stock and bought 482,776 units worth $5,546,282 . The most active insiders traders include Tp Holdings, L.P.Kep Tp Hol..., Frank Kberney Philip E Love..., and Stephen C.Edgerton Matthew .... On average, Third Point Reinsurance Ltd executives and independent directors trade stock every 64 days with the average trade being worth of $5,691,993. The most recent stock trade was executed by Medhi Mahmud on 13 August 2020, trading 12,000 units of TPRE stock currently worth $105,000.

What does Third Point Reinsurance Ltd do?

Complete history of Daniel Loeb stock trades at Ligand Pharmaceuticals and Third Point Reinsurance Ltd

Third Point Reinsurance Ltd executives and stock owners

Third Point Reinsurance Ltd executives and other stock owners filed with the SEC include:

• Daniel Malloy,
  Chief Executive Officer, Director
• Christopher Coleman,
  Chief Financial Officer
• David Govrin,
  President of Third Point Re USA
• Nicholas Campbell,
  Chief Risk Officer
• Janice Weidenborner,
  Executive Vice President, Group General Counsel
• Mark Parkin,
  Independent Director
• Gretchen Hayes,
  Independent Director
• Rafe de la Gueronniere,
  Independent Director
• Siddhartha Sankaran,
  Chairman of the Board
• Joseph Dowling,
  Director
• David Junius,
  Chief Operating Officer
• Mehdi Mahmud,
  Director
• Justin Brenden,
  Chief Reserving Actuary
• Yan Leclerc,
  Chief Accounting Officer
• Joshua Targoff,
  Director
• Mary R Hennessy,
  Director
• Gary Douglas Walters,
  Director
• Tonya L. Marshall,
  EVP, Gen Counsel and Secretary
• Anthony Urban,
  EVP, Underwriting
• Brook Lvr, L.P.Pbra (Cayman...,
  
• John R. Berger,
  Chairman, CEO & CUO
• Steven Elliot Fass,
  Director
• Thomas C. Wafer,
  Pres., Third Point Re USA Ltd.
• J. Robert Bredahl,
  President and COO
• Jonathan Norton,
  Chief Reserving Actuary
• Neil Mcconachie,
  Director
• Manoj K. Gupta,
  SVP, Underwriting
• Stephen C.Edgerton Matthew ...,
  
• Frank Kberney Philip E Love...,
  
• Tp Holdings, L.P.Kep Tp Hol...,
  
• Daniel S Loeb,
  10% owner
• Sid Sankaran,
  Director
• Michael Mc Knight,
  Chief Actuary & CRO
• Medhi Mahmud,
  Director